The gene therapy could end the need for people with haemophilia B to give themselves weekly injections of clotting factors. AFP
The gene therapy could end the need for people with haemophilia B to give themselves weekly injections of clotting factors. AFP
Gene therapy reduces risk of bleeding in haemophilia B patients
Single treatment could remove the need for regular injections by sufferers
